Literature DB >> 11912401

The relationship of serum testosterone to erectile function in normal aging men.

Ernani Luis Rhoden1, Claudio Telöken, Paulo Roberto Sogari, Carlos Ary Vargas Souto.   

Abstract

PURPOSE: We evaluated the variation in serum testosterone in normal aging men and its relationship with erectile function.
MATERIALS AND METHODS: In a study that was not community based and during a free screening program for prostate cancer 1,071 men were invited to complete a sexual activity questionnaire, that is the abridged 5-item version of the International Index of Erectile Function (IIEF-5), as a diagnostic tool for erectile dysfunction. Possible scores on the IIEF-5 are 1 to 25 and erectile dysfunction was classified into 5 categories based on the scores, namely severe-1 to 7, moderate-8 to 11, mild to moderate-12 to 16, mild-17 to 21 and none-22 to 25. Serum total testosterone was measured between 8:00 and 10:00 a.m. in all men.
RESULTS: Of the 1,071 men 965 (90.1%) were included in this study, of whom 88% were white and 12% were black. Mean age was 60.7 years. In this sample the prevalence of all degrees of erectile dysfunction was estimated to be 53.9%. The degree of erectile dysfunction was mild in 21.5% of cases, mild to moderate in 14.1%, moderate in 6.3% and severe in 11.9%. According to age the erectile dysfunction rate was 36.4% in the 40 to 49, 42.5% in the 50 to 59, 58.1% in the 60 to 69, 79.4% in the 70 to 79 and 100% in the 80 years and older groups (p <0.05). The variation in mean serum total testosterone in the age groups was not statistically significantly different (p >0.05). Pearson coefficients of age and total testosterone did not reveal any significant correlation (r = 0.00376, p = 0.907), similar to IIEF-5 score and total testosterone (r = 0.0163, p = 0.612). However, analysis of the variables IIEF-5 and age showed a statistically significant inverse or negative relationship (r = -0.3449, p <0.05).
CONCLUSIONS: Erectile dysfunction showed a clear association with aging but no consistent correlation of total testosterone with erectile condition was identified.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11912401

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  17 in total

Review 1.  Epidemiology of erectile dysfunction.

Authors:  Stanley G Korenman
Journal:  Endocrine       Date:  2004 Mar-Apr       Impact factor: 3.633

Review 2.  The treatment of late-onset hypogonadism.

Authors:  Oktay Üçer; Bilal Gümüş
Journal:  Turk J Urol       Date:  2014-03-24

Review 3.  The role of testosterone in erectile dysfunction.

Authors:  Giovanni Corona; Mario Maggi
Journal:  Nat Rev Urol       Date:  2009-12-08       Impact factor: 14.432

Review 4.  Male late-onset hypogonadism: pathogenesis, diagnosis and treatment.

Authors:  Ilpo Huhtaniemi; Gianni Forti
Journal:  Nat Rev Urol       Date:  2011-04-19       Impact factor: 14.432

Review 5.  Androgen replacement in men with hypogonadism and erectile dysfunction.

Authors:  Marion Albrecht-Betancourt; Rabih A Hijazi; Glenn R Cunningham
Journal:  Endocrine       Date:  2004 Mar-Apr       Impact factor: 3.633

Review 6.  Which patients with sexual dysfunction are suitable for testosterone replacement therapy?

Authors:  A Morelli; G Corona; S Filippi; S Ambrosini; G Forti; L Vignozzi; M Maggi
Journal:  J Endocrinol Invest       Date:  2007-11       Impact factor: 4.256

Review 7.  Testosterone deficiency in the aging male.

Authors:  J Abram McBride; Culley C Carson; Robert M Coward
Journal:  Ther Adv Urol       Date:  2016-02

8.  Testosterone is associated with erectile dysfunction: a cross-sectional study in Chinese men.

Authors:  Ming Liao; Xianghua Huang; Yong Gao; Aihua Tan; Zheng Lu; Chunlei Wu; Youjie Zhang; Xiaobo Yang; Haiying Zhang; Xue Qin; Zengnan Mo
Journal:  PLoS One       Date:  2012-06-21       Impact factor: 3.240

9.  The relationship of serum and salivary cortisol levels to male sexual dysfunction as measured by the International Index of Erectile Function.

Authors:  Y Kobori; E Koh; K Sugimoto; K Izumi; K Narimoto; Y Maeda; H Konaka; A Mizokami; T Matsushita; T Iwamoto; M Namiki
Journal:  Int J Impot Res       Date:  2009-05-07       Impact factor: 2.896

10.  Sexual asthenia: Tradamixina versus Tadalafil 5 mg daily.

Authors:  Fabrizio Iacono; Domenico Prezioso; Ester Illiano; Giuseppe Romeo; Antonio Ruffo; Bruno Amato
Journal:  BMC Surg       Date:  2012-11-15       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.